Morningstar
•
Jun 09, 2026
Perrigo Company plc: Perrigo: Leadership Transition Raises More Questions, but Could Prove Strategic
Summary
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm’s product mix is anchored
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Biogen Inc.
Sep 03, 2026
•
BIIB
Analyst Report: PVH Corp.
Sep 03, 2026
•
PVH
XRAY: What does Argus have to say about XRAY?
Sep 02, 2026
•
XRAY
PVH: Lowering target price to $62.00
Sep 02, 2026
•
PVH
RMD: Lowering target price to $255.00
Sep 02, 2026
•
RMD
